SAGE Therapeutics Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest SAGE Therapeutics' careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

**Overview** **POSITION DESCRIPTION** **Title:** **Director, Patient Services Programs, Planning, and PS Business Intelligence** **Reports to: Thomas Marinello** **General Scope and Summary** Sage is currently b...
Posted: January 21, 2018, 9:19 am
**Overview** **General Scope and Summary** SAGE Therapeutics is searching for a highly motivated and experienced individual for the position of Director of Health Economics, Outcomes Research (HEOR) and Value Demonstration. This Dire...
Posted: January 19, 2018, 9:04 am
**Overview** **Title: Area Sales Director (North East)** **Reports to: VP Sales and Account Management** **Location: Field based within Area geography** **General Scope and Summary**...
Posted: January 17, 2018, 10:16 am
**Overview** **Title: Area Sales Director (Mid West)** **Reports to: VP Sales and Account Management** **Location: Field based within Area geography** **General Scope and Summary** ...
Posted: January 17, 2018, 10:16 am
**Overview** **Title: Area Sales Director (South)** **Reports to: VP Sales and Account Management** **Location:** **Field based within Area geography** **General Scope and Summary*...
Posted: January 17, 2018, 10:16 am

Viewing page 1 of 13|Next Page

  Newsfeed | Subscribe  

HTF Market Report released a new research document of 34 pages on industry titled as ‘Encephalitis – Pipeline Review, H1 2018’ with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that import...
Posted: January 19, 2018, 4:56 am
For a hedged play on Sage Therapeutics (SAGE) MarketIntelligenceCenter.com’s patented trade-picking algorithms selected a Feb 16, 2018 $170 covered call for a net debit in the $161.69 area. That is also the break-even stock price for the covered c...
Posted: January 12, 2018, 12:00 am
Bloomberg Markets with Carol Massar and Cory Johnson. GUESTS: Jeffrey M Jonas President/CEO Sage Therapeutics Inc Discussing 2018 pipeline updates and key initiatives for the biopharmaceutical company. Christopher R O’Neill Chief Executive Officer...
Posted: January 10, 2018, 1:41 pm
Sage Therapeutics Inc. (SAGE) had a good day on the market for Tuesday January 09 as shares jumped 5.17% to close at $171.01. About 1.06 million shares traded hands on 10,007 trades for the day, compared with an average daily volume of 907,867 sha...
Posted: January 10, 2018, 10:01 am
Sage Therapeutics (SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on January 2, 2018, the Compensation Committee of Sage’s Board of ...
Posted: January 1, 2018, 4:00 pm

Viewing page 1 of 2|Next Page